09:02 AM EST, 11/04/2025 (MT Newswires) -- Aurinia Pharmaceuticals ( AUPH ) reported Q3 earnings Tuesday of $0.23 per diluted share, up from $0.10 a year earlier.
Analysts polled by FactSet expected $0.16.
Total revenue for the quarter ended Sept. 30 was $73.5 million, up from $67.8 million a year earlier.
Analysts polled by FactSet expected $67.7 million.
The company said it now expects 2025 total revenue of $275 million to $280 million, up from its earlier guidance of between $260 million and $270 million. Analysts polled by FactSet expect $270.5 million.